DailyDoctor Archive Specialties Get app
All ophthalmology briefings

The edition · Ophthalmology

HER2 antibody-drug conjugates damaged the ocular surface in 18 of 21 patients within a month

A prospective study describes vortex keratopathy and corneal nerve loss with HER2-targeted ADCs; half of endothelial grafts fail by three years after a tube shunt; a 17-million-procedure registry sets endophthalmitis rates by operation; glaucoma suspect follow-up can be risk-stratified; and Diwali firecracker injuries remain mostly in children.

The edition in brief

In a prospective study of 21 patients with HER2-positive breast cancer on HER2-targeted antibody-drug conjugates, 18 (85.7%) developed ocular surface toxicity at a mean of 28 days, progressing from inferior microcysts to vortex keratopathy, with subepithelial nerve loss and reduced sensitivity; changes were dose- and time-dependent and partly reversible. A meta-analysis of 22 retrospective studies (943 grafts) found 36-month endothelial keratoplasty survival of 57% after prior glaucoma surgery and 50% after a glaucoma drainage device, with 63% endothelial cell loss at 12 months in drainage device eyes. The IRIS Registry analysis of 17.5 million procedures (2016–2024) put endophthalmitis at about 1 in 106 after adult open-globe repair, 1 in 2,652 after cataract surgery and similar after standalone MIGS, and higher after paediatric than adult cataract surgery. In 83,305 US glaucoma suspects, conversion to glaucoma ran at 9.4% in the first year and 5.3% a year thereafter, from 2.0% a year in untreated patients under 50 to 16.7% in treated patients over 70. A three-centre Indian study of 67 Diwali firecracker eye injuries found 62.7% were children, a third bystanders, and over 40% presented worse than 6/60.

In this edition
01
Clinical update

Only half of endothelial grafts survive three years after a glaucoma drainage device

Counsel patients with a glaucoma drainage device that an endothelial graft has about a 50% chance of surviving three years.

1 min · American journal of ophthalmologyRead →
Primary outcome
Graft survival
Effect
36-month survival 57% overall (48 to 66%); 50% after drainage device (42 to 57%)
02Research

Endophthalmitis rates by procedure from 17.5 million operations

Quote procedure-specific endophthalmitis risk at consent — about 1 in 2,650 for adult cataract surgery and 1 in 106 after open-globe repair.

1 min · OphthalmologyRead →
03Research

Glaucoma suspects converted at about 5% a year after the first year

Set glaucoma suspect follow-up by risk: closer for older and treated patients, longer for young untreated suspects with stable tests.

1 min · American journal of ophthalmologyRead →
04Research

Diwali firecracker eye injuries: mostly children, a third bystanders

Plan emergency eye cover for Diwali, and advise families that children and bystanders account for most firecracker eye injuries.

1 min · Indian journal of ophthalmologyRead →
05Pearl

Shield, don't press, after a firecracker injury

After a firecracker eye injury, shield without pressure, irrigate contamination and refer urgently if the globe may be open.

1 minRead →
06
Practice changer

Examine the ocular surface before and during HER2 antibody-drug conjugate therapy

Examine the ocular surface at baseline and within a month of starting a HER2-targeted antibody-drug conjugate, and manage toxicity with the oncology team.

1 min · The British journal of ophthalmologyRead →
Primary outcome
Incidence and features of ocular surface toxicity
Effect
18/21 (85.7%) affected; mean onset 28 days

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free